Mumbai-based B2B pharma distribution platform Fundly.ai has raised $4 million from existing investors Accel and Multiply, along with venture debt of $0.9 million. Founded in 2021, Fundly started as a supply-chain finance platform for pharma companies but has since expanded into three interconnected businesses: B2B commerce, transaction and settlement infrastructure, and embedded credit.